Literature DB >> 404365

Neisseria meningitidis infections in Northern Norway: an epidemic in 1974-1975 due mainly to group B organisms.

K Bovre, E Holten, H Vik-Mo, A Brondbo, D Bratlid, P Bjark, P J Moe.   

Abstract

A severe epidemic of disease due to Neisseria meningitidis has been occurring in northern Norway since 1974. Based on bacteriological and clinical examination of cases during the 18 months between January 1, 1974 and June 30, 1975, an overall attack rate of 26.3 cases per 100,000 population per year has been calculated. The attack rates were highest in 1975 (total, 37.4 cases per 100,000 population; Troms County, 54.5) and in children younger than four years (total, 173.6; Troms County, 328.9). The epidemic shows a total case-fatality ratio of 14.1%. The highest case fatality ratio was recorded for patients older than 20 years (25.0%). Among the youngest children, cases were distinctly more frequent in males than females; in older children and adults, male patients had a clearly higher case-fatility ratio than female patients. Of the three serogroups of N. meningitidis, group B caused more cases of infection that groups A and C together. In addition, the causative meningococcal strains were almost uniformly resistant to high concentrations of sulfonamide. Both of these traits appear to have developed in northern Norway at or shortly before the time when the epidemic began.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404365     DOI: 10.1093/infdis/135.4.669

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978.

Authors:  E Holten
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

Review 2.  Bacterial outer membrane vesicles in disease and preventive medicine.

Authors:  Can M Unal; Viveka Schaar; Kristian Riesbeck
Journal:  Semin Immunopathol       Date:  2010-12-12       Impact factor: 9.623

3.  Antibody response in group B meningococcal disease determined by enzyme-linked immunosorbent assay with serotype 15 outer membrane antigen.

Authors:  S Harthug; E Rosenqvist; E A Høiby; T W Gedde-Dahl; L O Frøholm
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

4.  Clinical aspects of meningococcal infections.

Authors:  V K Paul; I C Verma; A K Deorari
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

5.  Applications of restriction endonuclease fingerprinting of chromosomal DNA of Neisseria meningitidis.

Authors:  B Bjorvatn; V Lund; B E Kristiansen; L Korsnes; O Spanne; B Lindqvist
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

Review 6.  The meningococcus and mechanisms of pathogenicity.

Authors:  I W DeVoe
Journal:  Microbiol Rev       Date:  1982-06

7.  Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland.

Authors:  O V Renkonen; A Sivonen; R Visakorpi
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

8.  Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.

Authors:  Dan M Granoff; Serena Giuntini; Flor A Gowans; Eduardo Lujan; Kelsey Sharkey; Peter T Beernink
Journal:  JCI Insight       Date:  2016-09-08

9.  Bacterial meningitis in Egypt: analysis of CSF isolates from hospital patients in Cairo, 1977-78.

Authors:  N Guirguis; K Hafez; M A El Kholy; J B Robbins; E C Gotschlich
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

10.  Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.

Authors:  Peter T Beernink; Dan M Granoff
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.